KR100321854B1 - 루테이나이징 호르몬 릴리싱 호르몬 동족체를 함유하는 장기 서방출성 미립구 및 그의 제조방법 - Google Patents
루테이나이징 호르몬 릴리싱 호르몬 동족체를 함유하는 장기 서방출성 미립구 및 그의 제조방법 Download PDFInfo
- Publication number
- KR100321854B1 KR100321854B1 KR1019980062142A KR19980062142A KR100321854B1 KR 100321854 B1 KR100321854 B1 KR 100321854B1 KR 1019980062142 A KR1019980062142 A KR 1019980062142A KR 19980062142 A KR19980062142 A KR 19980062142A KR 100321854 B1 KR100321854 B1 KR 100321854B1
- Authority
- KR
- South Korea
- Prior art keywords
- release
- microspheres
- lhrh
- polymer
- homologue
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
Abstract
Description
실시예 | 약물봉입율(%) | 평균입자크기(㎛) |
1 | 10.76 | 138.5 |
2 | 9.98 | 106.8 |
3 | 10.21 | 122.1 |
4 | 10.71 | 11.2 |
5 | 10.32 | 10.6 |
6 | 11.21 | 10.4 |
Claims (5)
- 락타이드와 글리코라이드의 공중합체에 LHRH 동족체를 봉입시켜 구성되는 서방출성 미립구에 있어서, 상기 미립구내에서 LHRH 동족체와 소수성이온쌍짓기가 가능하고, 유기용매에 직접 가용화되는 방출속도제어물질로서 올레인산나트륨, 디옥시콜린산, 콜린산, 지방산, 포스파티딘산의 군으로부터 선택된 1종을 함유함을 특징으로 하는 LHRH 동족체가 함유된 장기 서방출성 미립구.
- 제 1항에 있어서, LHRH 동족체는 초산 고세레린, 초산 나파레린, 초산 부세레린 또는 초산 루프로레린 중에서 선택된 어느 성분을 함유함을 특징으로 하는 LHRH 동족체가 함유된 장기 서방출성 미립구.
- 제 1항에 있어서, 상기 공중합체는 말단이 도데실기와 카르복실기를 갖는 폴리락타이드와 폴리글리코라이드의 고분자공중합체로서 LHRH 동족체와 결합하여 소수성 상호작용을 하는 미립구임을 특징으로 하는 LHRH 동족체가 함유된 장기 서방출성 미립구.
- 보조용매를 사용하여 LHRH 동족체를 용해한 후, 락타이드와 글리코라이드의 공중합체를 용해시킨 유기용매에 상기 LHRH 동족체의 용해액을 가하여 유상을 제조하고, 상기 얻어진 유상을 수상에 분산시키는 O/W형 단일유화방법에 의해 서방출성미립구를 제조하는 방법에 있어서,상기 LHRH 동족체의 용해시 보조용매에 방출속도제어물질로서 올레인산나트륨, 디옥시콜린산, 콜린산, 지방산, 포스파티딘산의 군으로부터 선택된 1종을 함께 용해하는 단계를 포함함을 특징으로 하는 LHRH 동족체가 함유된 장기 서방출성 미립구의 제조방법.
- 제 4항 있어서, 상기 보조용매는 엔-메틸-2-피로리딘으로 함을 특징으로 하는 LHRH 동족체가 함유된 장기 서방출성 미립구의 제조방법.
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019980062142A KR100321854B1 (ko) | 1998-12-30 | 1998-12-30 | 루테이나이징 호르몬 릴리싱 호르몬 동족체를 함유하는 장기 서방출성 미립구 및 그의 제조방법 |
TR2001/01913T TR200101913T2 (tr) | 1998-12-30 | 1999-02-11 | Lüteojenik hormon salan hormon analoglarını muhafaza eden salımı uzatılmış mikro-küre ve bu mikro-küreyi hazırlama yöntemi. |
JP2000592014A JP2002534392A (ja) | 1998-12-30 | 1999-02-11 | 黄体化ホルモン放出ホルモン類似体をカプセル化する持続放出性のマイクロスフェアおよびその調製方法 |
CA002358495A CA2358495A1 (en) | 1998-12-30 | 1999-02-11 | Prolonged release microsphere encapsulating luteinizing hormone-releasing hormone analogues and method for preparing the same |
CN99815239A CN1348383A (zh) | 1998-12-30 | 1999-02-11 | 包裹黄体素-释放激素类似物的缓释微球体和制备这种微球体的方法 |
PCT/KR1999/000071 WO2000040259A1 (en) | 1998-12-30 | 1999-02-11 | Prolonged release microsphere encapsulating luteinizing hormone-releasing hormone analogues and method for preparing the same |
MXPA01005540A MXPA01005540A (es) | 1998-12-30 | 1999-02-11 | Microesferas de liberacion prolongada para encapsular analogos de la hormona liberadora de la hormona luteinizante y metodo para prepararlas. |
BR9916945-2A BR9916945A (pt) | 1998-12-30 | 1999-02-11 | Microesferas de liberação prolongada encapsulando análagos de hormÈnio liberador de hormÈnio luteinizante e método para preparar microesferas de liberação prolongada |
ZA9902059A ZA992059B (en) | 1998-12-30 | 1999-03-15 | Prolonged release microsphere encapsulating luteinizing hormone-releasing hormone analogues and methods for preparing the same. |
ARP990101361A AR017480A1 (es) | 1998-12-30 | 1999-03-26 | Microesferas de liberacion prolongada para encapsular analogos de la hormona liberadora de hormona luteinizante y metodo para prepararlos |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019980062142A KR100321854B1 (ko) | 1998-12-30 | 1998-12-30 | 루테이나이징 호르몬 릴리싱 호르몬 동족체를 함유하는 장기 서방출성 미립구 및 그의 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20000045577A KR20000045577A (ko) | 2000-07-25 |
KR100321854B1 true KR100321854B1 (ko) | 2002-08-28 |
Family
ID=19568831
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019980062142A KR100321854B1 (ko) | 1998-12-30 | 1998-12-30 | 루테이나이징 호르몬 릴리싱 호르몬 동족체를 함유하는 장기 서방출성 미립구 및 그의 제조방법 |
Country Status (10)
Country | Link |
---|---|
JP (1) | JP2002534392A (ko) |
KR (1) | KR100321854B1 (ko) |
CN (1) | CN1348383A (ko) |
AR (1) | AR017480A1 (ko) |
BR (1) | BR9916945A (ko) |
CA (1) | CA2358495A1 (ko) |
MX (1) | MXPA01005540A (ko) |
TR (1) | TR200101913T2 (ko) |
WO (1) | WO2000040259A1 (ko) |
ZA (1) | ZA992059B (ko) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6565874B1 (en) | 1998-10-28 | 2003-05-20 | Atrix Laboratories | Polymeric delivery formulations of leuprolide with improved efficacy |
US8470359B2 (en) | 2000-11-13 | 2013-06-25 | Qlt Usa, Inc. | Sustained release polymer |
WO2003075958A1 (fr) | 2002-03-11 | 2003-09-18 | Takeda Chemical Industries, Ltd. | Medicaments permettant de traiter une maladie dependant d'une hormone sexuelle |
WO2003105917A2 (en) | 2002-06-12 | 2003-12-24 | Scimed Life Systems, Inc. | Bulking agents |
DK1532985T3 (en) | 2002-06-25 | 2016-12-05 | Takeda Pharmaceuticals Co | PROCEDURE FOR PREPARING A COMPOSITION WITH LONG-TERM RELEASE |
CA2533314C (en) * | 2003-07-18 | 2013-07-09 | Oakwood Laboratories, L.L.C. | Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions |
BR0305373A (pt) * | 2003-11-06 | 2005-06-28 | Iseu Da Silva Nunes Nelson Edu | Imunomodulador agregado proteico de anidrido de fosfolinoleato-palmitoleato de amÈnia e magnésio e processo de sua obtenção e formulação |
TW200529890A (en) | 2004-02-10 | 2005-09-16 | Takeda Pharmaceutical | Sustained-release preparations |
KR100622996B1 (ko) * | 2005-03-03 | 2006-09-14 | 한국과학기술원 | 약물이 봉입된 비다공성 고분자 미립 담체 및 이의 제조방법 |
US7963287B2 (en) | 2005-04-28 | 2011-06-21 | Boston Scientific Scimed, Inc. | Tissue-treatment methods |
US9463426B2 (en) | 2005-06-24 | 2016-10-11 | Boston Scientific Scimed, Inc. | Methods and systems for coating particles |
WO2009150136A1 (de) * | 2008-06-09 | 2009-12-17 | Boehringer Ingelheim International Gmbh | Neue einbettungspartikel für die inhalation |
CN104873979A (zh) | 2008-08-29 | 2015-09-02 | 健赞股份有限公司 | 控释肽制剂 |
KR101663560B1 (ko) * | 2009-02-13 | 2016-10-10 | 동국제약 주식회사 | 균일한 서방출성 미립구의 제조방법 |
DE102011114864A1 (de) | 2011-10-05 | 2013-04-11 | Acino Ag | Verfahren zur Herstellung einer homogenen Pulvermischung und Verfahren zur Herstellung eines Implantats sowie Implantat |
HUE045661T2 (hu) | 2011-12-14 | 2020-01-28 | Abraxis Bioscience Llc | Polimer segédanyagok alkalmazása részecskék liofilizálásához vagy fagyasztásához |
BR112016002342A8 (pt) * | 2013-08-06 | 2018-01-23 | Dong Kook Pharm Co Ltd | microesfera entecavir, método para preparação de uma microesfera entecavir, e, composição farmacêutica |
CN109394705B (zh) * | 2018-12-04 | 2021-11-19 | 沈阳药科大学 | 一种戈舍瑞林缓释微球冻干粉及其制备方法 |
US11617720B2 (en) | 2020-05-08 | 2023-04-04 | M. Technique Co., Ltd. | Main agent uniformly dispersed microsphere and a sustained release formulation comprising the same |
KR20220163418A (ko) * | 2020-05-08 | 2022-12-09 | 엠. 테크닉 가부시키가이샤 | 생리 활성 물질이 균일하게 분산된 마이크로스피어 및 그것을 함유하는 서방성 제제 |
KR20220163416A (ko) | 2020-05-08 | 2022-12-09 | 엠. 테크닉 가부시키가이샤 | 생리 활성 물질이 균일하게 분산된 마이크로스피어 및 그것을 함유하는 서방성 제제 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4675189A (en) * | 1980-11-18 | 1987-06-23 | Syntex (U.S.A.) Inc. | Microencapsulation of water soluble active polypeptides |
CH661206A5 (fr) * | 1983-09-23 | 1987-07-15 | Debiopharm Sa | Procede pour la preparation d'un medicament destine au traitement de maladies hormonodependantes. |
CH660302A5 (fr) * | 1984-10-17 | 1987-04-15 | Debiopharm Sa | Procede de micro-encapsulation en phase heterogene de substances medicamenteuses hydrosolubles. |
GB2209937B (en) * | 1987-09-21 | 1991-07-03 | Depiopharm S A | Water insoluble polypeptides |
YU48420B (sh) * | 1991-03-25 | 1998-07-10 | Hoechst Aktiengesellschaft | Postupak za dobijanje biološki razgradljivih mikročestica sa dugotrajnim delovanjem |
FR2693905B1 (fr) * | 1992-07-27 | 1994-09-02 | Rhone Merieux | Procédé de préparation de microsphères pour la libération prolongée de l'hormone LHRH et ses analogues, microsphères et formulations obtenues. |
-
1998
- 1998-12-30 KR KR1019980062142A patent/KR100321854B1/ko not_active IP Right Cessation
-
1999
- 1999-02-11 CN CN99815239A patent/CN1348383A/zh active Pending
- 1999-02-11 CA CA002358495A patent/CA2358495A1/en not_active Abandoned
- 1999-02-11 WO PCT/KR1999/000071 patent/WO2000040259A1/en not_active Application Discontinuation
- 1999-02-11 TR TR2001/01913T patent/TR200101913T2/xx unknown
- 1999-02-11 BR BR9916945-2A patent/BR9916945A/pt not_active Application Discontinuation
- 1999-02-11 MX MXPA01005540A patent/MXPA01005540A/es unknown
- 1999-02-11 JP JP2000592014A patent/JP2002534392A/ja active Pending
- 1999-03-15 ZA ZA9902059A patent/ZA992059B/xx unknown
- 1999-03-26 AR ARP990101361A patent/AR017480A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP2002534392A (ja) | 2002-10-15 |
TR200101913T2 (tr) | 2001-11-21 |
CN1348383A (zh) | 2002-05-08 |
AR017480A1 (es) | 2001-09-05 |
CA2358495A1 (en) | 2000-07-13 |
BR9916945A (pt) | 2001-11-06 |
MXPA01005540A (es) | 2004-06-22 |
ZA992059B (en) | 1999-09-27 |
WO2000040259A1 (en) | 2000-07-13 |
KR20000045577A (ko) | 2000-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100321854B1 (ko) | 루테이나이징 호르몬 릴리싱 호르몬 동족체를 함유하는 장기 서방출성 미립구 및 그의 제조방법 | |
CA2100925C (en) | Process for preparing microspheres for the prolonged release of the lhrh hormone and its analogues, microspheres and formulations obtained | |
KR100293882B1 (ko) | 카르복시말단폴리에스테르와펩티드와의염 | |
DE69730093T2 (de) | Zubereitung mit verzögerter Freisetzung | |
US6506410B1 (en) | Sustained release microparticle and method for preparing the same | |
RU2103994C1 (ru) | Композиция в форме микросфер для пролонгированного и контролируемого высвобождения пептидного лекарственного вещества | |
KR101113044B1 (ko) | 용매교류증발법에 의한 서방출성 미립구의 제조방법 | |
JP2010174021A6 (ja) | 徐放型生物分解性微小球およびその製造方法 | |
JP2010174021A (ja) | 徐放型生物分解性微小球およびその製造方法 | |
NZ239381A (en) | A microcapsule designed for zero order release of a polypeptide | |
JPH0769929A (ja) | 薬剤学的又は獣医学的認容性で、両親媒性の非架橋線状、枝分れ又はグラフトブロックコポリマーの製造方法 | |
EP3175847A1 (en) | Pharmaceutical composition containing leuprolide and having both immediate and sustained release properties | |
US20100143479A1 (en) | Method of making sustained release microparticles | |
US8329863B2 (en) | Gonadotropin releasing hormone antagonists | |
DK1532985T3 (en) | PROCEDURE FOR PREPARING A COMPOSITION WITH LONG-TERM RELEASE | |
KR101663560B1 (ko) | 균일한 서방출성 미립구의 제조방법 | |
KR20100094227A (ko) | 서방출성 미립구의 제조방법 | |
Woo et al. | In vitro characterization and in vivo testosterone suppression of 6-month release poly (D, L-lactide) leuprolide microspheres | |
KR100566573B1 (ko) | Lhrh 동족체를 함유하는 서방성 미립구의 제조방법 | |
KR101961848B1 (ko) | C18:1, c18:1(oh) 또는 c18:2의 장쇄 지방산이 포함된 오일류를 포함한 방출억제제를 적용한 서방출성 마이크로스피어 및 이의 제조방법 | |
KR101039237B1 (ko) | 새로운 용출률이 개선된 서방출성 미립구의 제조방법 | |
KR20240031868A (ko) | 류프롤라이드를 포함하는 서방형 미립구, 이를 포함하는 주사제제 및 이의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130103 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20140103 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20150105 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20160105 Year of fee payment: 15 |
|
FPAY | Annual fee payment |
Payment date: 20170104 Year of fee payment: 16 |
|
FPAY | Annual fee payment |
Payment date: 20180104 Year of fee payment: 17 |
|
EXPY | Expiration of term |